X

Panacea Biotec Q4FY23 Earnings Story

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in the year 1995. Panacea Biotec is a research based Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars.

Financial Results:

  • Panacea Biotec Ltd. reported Total Income for Q4FY23 of ₹ 144 Crores up from ₹ 145 Crore year on year, a fall of 0.54%.

  • Total Expenses for Q4FY23 of ₹ 145 Crores up from ₹ 213 Crores year on year, fall of 32%.

  • Consolidated Net Profit of ₹ (13) Crores, down from ₹ 1,237 Crores in the same quarter of the previous year.

  • The Earnings per Share is ₹ (2.07), up 61% from ₹ 202.03 in the same quarter of the previous year.
Related Post